Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Na Young | - |
dc.contributor.author | Yoon, Sang Jun | - |
dc.contributor.author | Han, Dae Hee | - |
dc.contributor.author | Gupta, Haripriya | - |
dc.contributor.author | Youn, Gi Soo | - |
dc.contributor.author | Shin, Min Jea | - |
dc.contributor.author | Ham, Young Lim | - |
dc.contributor.author | Kwak, Min Jung | - |
dc.contributor.author | Kim, Byung Yong | - |
dc.contributor.author | Yu, Jeong Seok | - |
dc.contributor.author | Lee, Do Yup | - |
dc.contributor.author | Park, Tae-Sik | - |
dc.contributor.author | Park, Si-Hyun | - |
dc.contributor.author | Kim, Byoung Kook | - |
dc.contributor.author | Joung, Hyun Chae | - |
dc.contributor.author | Choi, In Suk | - |
dc.contributor.author | Hong, Ji Taek | - |
dc.contributor.author | Kim, Dong Joon | - |
dc.contributor.author | Han, Sang Hak | - |
dc.contributor.author | Suk, Ki Tae | - |
dc.date.available | 2020-03-03T06:47:41Z | - |
dc.date.created | 2020-02-24 | - |
dc.date.issued | 2020-07 | - |
dc.identifier.issn | 1949-0976 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/17828 | - |
dc.description.abstract | Targeting the gut-liver axis by modulating the gut-microbiome can be a promising therapeutic approach in nonalcoholic fatty liver disease (NAFLD). The aim of this study was to evaluate the effects of single species and a combination of Lactobacillus and Pediococcus in NAFLD mice model. Six-week male C57BL/6J mice were divided into 9 groups (n = 10/group; normal, Western diet, and 7 Western diet-strains [10(9) CFU/g, 8 weeks]). The strains used were L. bulgaricus, L. casei, L. helveticus, P. pentosaceus KID7, and three combinations (1: L. casei+L. helveticus, 2: L. casei+L. helveticus+P. pentosaceus KID7, and 3: L. casei+L. helveticus+L. bulgaricus). Liver/Body weight ratio, serum and stool analysis, liver pathology, and metagenomics by 16S rRNA-sequencing were examined. In the liver/body ratio, L. bulgaricus (5.1 +/- 0.5), L. helveticus (5.2 +/- 0.4), P. pentosaceus KID7 (5.5 +/- 0.5), and combination1 and 2 (4.2 +/- 0.6 and 4.8 +/- 0.7) showed significant reductions compared with Western (6.2 +/- 0.6)(p < 0.001). In terms of cholesterol and steatosis/inflammation/NAFLD activity, all groups except for L. casei were associated with an improvement (p < .05). The elevated level of tumor necrosis factor-alpha/interleukin-1 beta (pg/ml) in Western (65.8 +/- 7.9/163.8 +/- 12.2) was found to be significantly reduced in L. bulgaricus (24.2 +/- 1.0/58.9 +/- 15.3), L. casei (35.6 +/- 2.1/62.9 +/- 6.0), L. helveticus (43.4 +/- 3.2/53.6 +/- 7.5), and P. pentosaceus KID7 (22.9 +/- 3.4/59.7 +/- 12.2)(p < 0.01). Cytokines were improved in the combination groups. In metagenomics, each strains revealed a different composition and elevated Firmicutes/Bacteroidetes ratio in the western (47.1) was decreased in L. bulgaricus (14.5), L. helveticus (3.0), and P. pentosaceus KID7 (13.3). L. bulgaricus, L. casei, L. helveticus, and P. pentosaceus KID7 supplementation can improve NAFLD-progression by modulating gut-microbiome and inflammatory pathway. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS INC | - |
dc.relation.isPartOf | GUT MICROBES | - |
dc.title | Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000508842600001 | - |
dc.identifier.doi | 10.1080/19490976.2020.1712984 | - |
dc.identifier.bibliographicCitation | GUT MICROBES, v.11, no.4, pp.882 - 899 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85078470498 | - |
dc.citation.endPage | 899 | - |
dc.citation.startPage | 882 | - |
dc.citation.title | GUT MICROBES | - |
dc.citation.volume | 11 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Park, Tae-Sik | - |
dc.contributor.affiliatedAuthor | Park, Si-Hyun | - |
dc.type.docType | Article; Early Access | - |
dc.subject.keywordAuthor | Nonalcoholic fatty liver disease | - |
dc.subject.keywordAuthor | gut liver axis | - |
dc.subject.keywordAuthor | liver function | - |
dc.subject.keywordAuthor | strains | - |
dc.subject.keywordAuthor | microbiome | - |
dc.subject.keywordPlus | PROBIOTICS | - |
dc.subject.keywordPlus | STEATOHEPATITIS | - |
dc.subject.keywordPlus | METFORMIN | - |
dc.subject.keywordPlus | SYSTEM | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalResearchArea | Microbiology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Microbiology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.